Effect of Alveolar Minute Ventilation on Respiratory Gas Heat Content
NCT ID: NCT01943227
Last Updated: 2019-10-28
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2013-08-31
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
One Lung Ventilation
NCT01997073
Pulmonary Vascular Effects of Respiratory Rate & Carbon Dioxide
NCT01927237
Resting Energy Expenditure in Patients With OHS Treated With Long-term NIV
NCT04474587
A Feasibility Study of a Low Tidal Volume Ventilation Strategy in One Lung Ventilation
NCT03467607
Non Invasive Ventilation (NIV) Related Practices, Monitoring of the NIV Treatment Effect and of the Patient's Comfort
NCT01692509
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
6ml/kg
Enthalpy measured in patients receiving controlled positive pressure ventilation 6ml/kg Tidal volume.
The VQm monitor samples the gas at a rate of 3 L/min, returning the analyzed gas to the circuit. As the exhaled gas passes through the analytical chamber, the temperature and humidity are measured essentially continuously (40Hz). These data are combined with pressure measurements to determine the exhaled gas volume and then the heat content (enthalpy) is calculated.
controlled positive pressure ventilation 6ml/kg tidal volume
controlled positive pressure ventilation 6ml/kg tidal volume
9ml/kg
Enthalpy measured in patients receiving controlled positive pressure ventilation 9ml/kg Tidal volume.
The VQm monitor samples the gas at a rate of 3 L/min, returning the analyzed gas to the circuit. As the exhaled gas passes through the analytical chamber, the temperature and humidity are measured essentially continuously (40Hz). These data are combined with pressure measurements to determine the exhaled gas volume and then the heat content (enthalpy) is calculated.
controlled positive pressure ventilation 9ml/kg tidal volume
controlled positive pressure ventilation 9ml/kg tidal volume
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
controlled positive pressure ventilation 9ml/kg tidal volume
controlled positive pressure ventilation 9ml/kg tidal volume
controlled positive pressure ventilation 6ml/kg tidal volume
controlled positive pressure ventilation 6ml/kg tidal volume
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* scheduled for an elective surgical procedure with an anticipated duration of more than 2 hours requiring general anesthesia and positive pressure ventilation using an endotracheal tube
* patient status ASA 1, 2 or 3
* no significant cardio-vascular or respiratory disease
* supine surgical position
Exclusion Criteria
* age less than 18 years
* pregnancy
* prisoners
* pre-existing cardiac or pulmonary disease
* infusion of inotropic drugs
* positive end expiratory pressure (PEEP) requirements \>8 cm H2O
* increased intra-abdominal pressure (e.g. planned surgical pneumoperitoneum or ascitis)
* intra-operative patient position other than supine
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Davis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Neal Fleming, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Professor, Anesthesiology & Pain Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UC Davis Health System
Sacramento, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
483184
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.